Cargando…
Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma
SIMPLE SUMMARY: Basal cell carcinoma (BCC) is the most common malignancy in humans with a range of treatment options available. Tumor and patient characteristics aid in risk-stratification, which influences treatment considerations. Here, we review the advancements in surgical, topical, field, immun...
Autores principales: | Chen, Olivia M., Kim, Keemberly, Steele, Chelsea, Wilmas, Kelly M., Aboul-Fettouh, Nader, Burns, Carrick, Doan, Hung Quoc, Silapunt, Sirunya, Migden, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367462/ https://www.ncbi.nlm.nih.gov/pubmed/35954384 http://dx.doi.org/10.3390/cancers14153720 |
Ejemplares similares
-
Advances in Cutaneous Squamous Cell Carcinoma Management
por: Burns, Carrick, et al.
Publicado: (2022) -
Sonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinoma
por: Doan, Hung Q, et al.
Publicado: (2016) -
Switching Hedgehog inhibitors and other strategies to address resistance when treating advanced basal cell carcinoma
por: Doan, Hung Q., et al.
Publicado: (2021) -
Social Media and Dermatology During the COVID-19 Pandemic: Analyzing User-Submitted Posts Seeking Dermatologic Advice on Reddit
por: Aboul-Fettouh, Nader, et al.
Publicado: (2023) -
Immunotherapy and Systemic Treatment of Cutaneous Squamous Cell Carcinoma
por: Aboul-Fettouh, Nader, et al.
Publicado: (2021)